List of Excipients in API insulin degludec
Excipients in NDA-approved (novel) drugs containing insulin degludec
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| A-S Medication Solutions | TRESIBA | insulin degludec | 50090-3491 | GLYCERIN | |
| A-S Medication Solutions | TRESIBA | insulin degludec | 50090-3491 | HYDROCHLORIC ACID | |
| A-S Medication Solutions | TRESIBA | insulin degludec | 50090-3491 | METACRESOL | |
| A-S Medication Solutions | TRESIBA | insulin degludec | 50090-3491 | PHENOL | |
| A-S Medication Solutions | TRESIBA | insulin degludec | 50090-3491 | SODIUM HYDROXIDE | |
| A-S Medication Solutions | TRESIBA | insulin degludec | 50090-3491 | WATER | |
| A-S Medication Solutions | TRESIBA | insulin degludec | 50090-3491 | ZINC | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for insulin degludec
Excipient focus: GLYCERIN
insulin degludec drug variants containing GLYCERIN
insulin degludec drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
insulin degludec drug variants containing HYDROCHLORIC ACID
insulin degludec drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Novo Nordisk | insulin degludec and liraglutide | 0169-2911 |
| >Company | >Ingredient | >NDC |
Excipient focus: METACRESOL
insulin degludec drug variants containing METACRESOL
insulin degludec drug variants not containing METACRESOL
| Company | Ingredient | NDC |
|---|---|---|
| Novo Nordisk | insulin degludec and liraglutide | 0169-2911 |
| >Company | >Ingredient | >NDC |
Excipient focus: PHENOL
insulin degludec drug variants containing PHENOL
insulin degludec drug variants not containing PHENOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
insulin degludec drug variants containing SODIUM HYDROXIDE
insulin degludec drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novo Nordisk | insulin degludec and liraglutide | 0169-2911 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
insulin degludec drug variants containing WATER
insulin degludec drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ZINC
insulin degludec drug variants containing ZINC
insulin degludec drug variants not containing ZINC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch